138 results on '"Wang, Yu‐Hung"'
Search Results
2. Stellae-123 gene expression signature improved risk stratification in Taiwanese acute myeloid leukemia patients
3. Higher MDMX expression was associated with hypomethylating agent resistance and inferior survival in MDS patients, inferring it a potential therapeutic target
4. Influence of TP53 gene mutations and their allelic status in myelodysplastic syndromes with isolated 5q deletion
5. Kinome expression profiling improves risk stratification and therapeutic targeting in myelodysplastic syndromes
6. The clinical and biological characterization of acute myeloid leukemia patients with S100A4 overexpression
7. Stem cell transplant for mantle cell lymphoma in Taiwan
8. IDH2 mutation accelerates TPO‐induced myelofibrosis with enhanced S100a8/a9 and NFκB signaling in vivo.
9. A CIBERSORTx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes
10. Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification
11. Influence of TP53gene mutations and their allelic status in myelodysplastic syndromes with isolated 5q deletion
12. Comparison of the effectiveness of Taiwanese college and high school students participating in creative contests
13. Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125
14. Correlative analysis of overall survival with clinical characteristics in 127 patients with mantle cell lymphoma: a multi-institutional cohort in Taiwan
15. P703: THE AIPSS-MDS MACHINE LEARNING MODEL PREDICTS OVERALL SURVIVAL AND LEUKEMIC TRANSFORMATION IN CMML: AN ANALYSIS OF THE SPANISH REGISTRY OF MDS
16. P726: TET2 ALLELIC BURDEN IMPRINTS A CONTEXT-DEPENDENT PROGNOSTIC SIGNIFICANCE OF ASXL1 MUTATION IN CHRONIC MYELOMONOCYTIC LEUKAEMIA
17. P720: A BONE MARROW MICROENVIRONMENTAL CELL SIGNATURE SCORING SYSTEM INDEPENDENTLY PREDICTED SURVIVAL AND DRUG RESISTANCE IN CHRONIC MYELOMONOCYTIC LEUKAEMIA PATIENTS
18. P691: MULTIOMIC SINGLE-CELL APPROACH REVEALED CLONAL ARCHITECTURE OF KIT MUTATIONS IN CHRONIC MYELOMONOCYTIC LEUKAEMIA PATIENTS WITH/WITHOUT SYSTEMIC MASTOCYTOSIS
19. S171: HIGHER MDMX EXPRESSION WAS ASSOCIATED WITH HYPOMETHYLATING AGENT RESISTANCE AND WORSE SURVIVAL IN MYELODYSPLASTIC SYNDROME PATIENTS, INFERRING IT A POTENTIAL THERAPEUTIC TARGET
20. ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
21. A three‐gene leukaemic stem cell signature score is robustly prognostic in chronic myelomonocytic leukaemia
22. Higher MDMXexpression was associated with hypomethylating agent resistance and inferior survival in MDS patients, inferring it a potential therapeutic target
23. Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromes.
24. High BM plasma S100A8/A9 is associated with a perturbed microenvironment and poor prognosis in myelodysplastic syndromes
25. Thermal Error Prediction of Ball Screws Based on Partial Least Square Method with Consideration of Friction Works
26. A Three Gene Leukemic Stem Cell Signature Score Is Robustly Prognostic in Chronic Myelomonocytic Leukemia
27. Integrative Analysis of Blast Phase Chronic Myelomonocytic Leukemia Reveals Distinct Transformation Phenotypes Predictive of Drug Response
28. The clinical and biological characterization of acute myeloid leukemia patients with S100A4 overexpression
29. Higher RUNX1 expression levels are associated with worse overall and leukaemia‐free survival in myelodysplastic syndrome patients
30. AML-222 Distinct Clinical and Biological Characteristics of Acute Myeloid Leukemia With Higher Expression of PIWIL4
31. MPN-239 Clinico-Molecular Risk Stratification in 284 Patients With Pre-Fibrotic and Overt Myelofibrosis
32. Clinico-Molecular Risk Stratification in 284 Patients With Pre-Fibrotic and Overt Myelofibrosis
33. Rituximab/Bendamustine or Rituximab/Ifosfamide/Carboplatin/Etoposide as Second-Line Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Real-World Analysis
34. Stem Cell Transplant for Mantle Cell Lymphoma in Taiwan
35. RUNX1 Expression Can be Complementary to RUNX1 Mutation in MDS Prognostication
36. Immune signatures of bone marrow cells can independently predict prognosis in patients with myelodysplastic syndrome
37. Busulfan‐containing conditioning regimens in allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: A Taiwan observational study
38. The Concept Study of Knowledge Value Added in Museum Digital Archives
39. The expression levels of long non‐coding RNA KIAA0125 are associated with distinct clinical and biological features in myelodysplastic syndromes
40. Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125
41. Next-Generation Sequencing Minimal Residual Disease of Mantle Cell Lymphoma in Autologous Stem Cell Grafts and Its Implication on Tumor Recurrence
42. Busulfan‐containing conditioning regimens in allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: A Taiwan observational study.
43. Hepatitis B reactivation during treatment of tyrosine kinase inhibitors—Experience in 142 adult patients with chronic myeloid leukemia
44. Effects of Far-Infrared Therapy on Foot Circulation Among Hemodialysis Patients With Diabetes Mellitus
45. A 4-gene leukemic stem cell score can independently predict the prognosis of myelodysplastic syndrome patients
46. Immune signatures of bone marrow cells can independently predict prognosis in patients with myelodysplastic syndrome.
47. Future directions in myelodysplastic syndromes/neoplasms and acute myeloid leukaemia classification: from blast counts to biology.
48. Effects of water-saving education in Taiwan on public water knowledge, attitude, and behavior intention change
49. Busulfan-Containing Conditioning Regimens in Allogeneic Hematopoietic Stem-Cell Transplantation for Acute Lymphoblastic Leukemia: Single Tertiary Center Experience in Taiwan
50. A Leukemic Stem Cell Signature-Based Scoring System Can Independently Predict the Prognosis of Myelodysplastic Syndrome Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.